▶ 調査レポート

フィトヘマグルチニン(PHA)の世界市場2023年:白血球反応性(L)、赤血球反応性(E)

• 英文タイトル:Global Phytohemagglutinin (PHA) Market Research Report 2023

QYResearchが調査・発行した産業分析レポートです。フィトヘマグルチニン(PHA)の世界市場2023年:白血球反応性(L)、赤血球反応性(E) / Global Phytohemagglutinin (PHA) Market Research Report 2023 / MRC23Q34003資料のイメージです。• レポートコード:MRC23Q34003
• 出版社/出版日:QYResearch / 2023年3月
• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(2-3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥435,000 (USD2,900)▷ お問い合わせ
  Enterprise License¥870,000 (USD5,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは世界のフィトヘマグルチニン(PHA)市場について調査・分析し、世界のフィトヘマグルチニン(PHA)市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析(白血球反応性(L)、赤血球反応性(E))、用途別セグメント分析(科学研究、工業生産)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Biowest、Thermo Fisher、Biological Industries、VWR、Francelab、Jain Biologicals、R&D Systems、Serox GmbH、Irvine Scientific、Cellseco、Cytivaなどが含まれています。世界のフィトヘマグルチニン(PHA)市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争による影響は、フィトヘマグルチニン(PHA)市場規模を推定する際に考慮しました。本レポートは、フィトヘマグルチニン(PHA)の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、フィトヘマグルチニン(PHA)に関するビジネス上の意思決定に役立てることを目的としています。

・フィトヘマグルチニン(PHA)市場の概要
- 製品の定義
- フィトヘマグルチニン(PHA)のタイプ別セグメント
- 世界のフィトヘマグルチニン(PHA)市場成長率のタイプ別分析(白血球反応性(L)、赤血球反応性(E))
- フィトヘマグルチニン(PHA)の用途別セグメント
- 世界のフィトヘマグルチニン(PHA)市場成長率の用途別分析(科学研究、工業生産)
- 世界市場の成長展望
- 世界のフィトヘマグルチニン(PHA)生産量の推定と予測(2018年-2029年)
- 世界のフィトヘマグルチニン(PHA)生産能力の推定と予測(2018年-2029年)
- フィトヘマグルチニン(PHA)の平均価格の推定と予測(2018年-2029年)
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- フィトヘマグルチニン(PHA)市場の競争状況およびトレンド

・フィトヘマグルチニン(PHA)の地域別生産量
- フィトヘマグルチニン(PHA)生産量の地域別推計と予測(2018年-2029年)
- 地域別フィトヘマグルチニン(PHA)価格分析(2018年-2023年)
- 北米のフィトヘマグルチニン(PHA)生産規模(2018年-2029年)
- ヨーロッパのフィトヘマグルチニン(PHA)生産規模(2018年-2029年)
- 中国のフィトヘマグルチニン(PHA)生産規模(2018年-2029年)
- 日本のフィトヘマグルチニン(PHA)生産規模(2018年-2029年)
- 韓国のフィトヘマグルチニン(PHA)生産規模(2018年-2029年)
- インドのフィトヘマグルチニン(PHA)生産規模(2018年-2029年)

・フィトヘマグルチニン(PHA)の地域別消費量
- フィトヘマグルチニン(PHA)消費量の地域別推計と予測(2018年-2029年)
- 北米のフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- アメリカのフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- ヨーロッパのフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- アジア太平洋のフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- 中国のフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- 日本のフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- 韓国のフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- 東南アジアのフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- インドのフィトヘマグルチニン(PHA)消費量(2018年-2029年)
- 中南米・中東・アフリカのフィトヘマグルチニン(PHA)消費量(2018年-2029年)

・タイプ別セグメント:白血球反応性(L)、赤血球反応性(E)
- 世界のフィトヘマグルチニン(PHA)のタイプ別生産量(2018年-2023年)
- 世界のフィトヘマグルチニン(PHA)のタイプ別生産量(2024年-2029年)
- 世界のフィトヘマグルチニン(PHA)のタイプ別価格

・用途別セグメント:科学研究、工業生産
- 世界のフィトヘマグルチニン(PHA)の用途別生産量(2018年-2023年)
- 世界のフィトヘマグルチニン(PHA)の用途別生産量(2024年-2029年)
- 世界のフィトヘマグルチニン(PHA)の用途別価格

・主要企業のプロファイル:企業情報、製品ポートフォリオ、生産量、価格、動向
Biowest、Thermo Fisher、Biological Industries、VWR、Francelab、Jain Biologicals、R&D Systems、Serox GmbH、Irvine Scientific、Cellseco、Cytiva

・産業チェーンと販売チャネルの分析
- フィトヘマグルチニン(PHA)産業チェーン分析
- フィトヘマグルチニン(PHA)の主要原材料
- フィトヘマグルチニン(PHA)の販売チャネル
- フィトヘマグルチニン(PHA)のディストリビューター
- フィトヘマグルチニン(PHA)の主要顧客

・フィトヘマグルチニン(PHA)市場ダイナミクス
- フィトヘマグルチニン(PHA)の業界動向
- フィトヘマグルチニン(PHA)市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

The global Phytohemagglutinin (PHA) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Phytohemagglutinin (PHA) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Phytohemagglutinin (PHA) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Phytohemagglutinin (PHA) include Biowest, Thermo Fisher, Biological Industries, VWR, Francelab, Jain Biologicals, R&D Systems, Serox GmbH and Irvine Scientific, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phytohemagglutinin (PHA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phytohemagglutinin (PHA).
The Phytohemagglutinin (PHA) market size, estimations, and forecasts are provided in terms of output/shipments (Liter) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Phytohemagglutinin (PHA) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phytohemagglutinin (PHA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Biowest
Thermo Fisher
Biological Industries
VWR
Francelab
Jain Biologicals
R&D Systems
Serox GmbH
Irvine Scientific
Cellseco
Cytiva
Segment by Type
Leukocyte Reactive (L)
Erythrocyte Reactive (E)
Segment by Application
Scientific Research
Industrial Production
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Phytohemagglutinin (PHA) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Phytohemagglutinin (PHA) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Phytohemagglutinin (PHA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

レポート目次

1 Phytohemagglutinin (PHA) Market Overview
1.1 Product Definition
1.2 Phytohemagglutinin (PHA) Segment by Type
1.2.1 Global Phytohemagglutinin (PHA) Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Leukocyte Reactive (L)
1.2.3 Erythrocyte Reactive (E)
1.3 Phytohemagglutinin (PHA) Segment by Application
1.3.1 Global Phytohemagglutinin (PHA) Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Global Market Growth Prospects
1.4.1 Global Phytohemagglutinin (PHA) Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Phytohemagglutinin (PHA) Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Phytohemagglutinin (PHA) Production Estimates and Forecasts (2018-2029)
1.4.4 Global Phytohemagglutinin (PHA) Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Phytohemagglutinin (PHA) Production Market Share by Manufacturers (2018-2023)
2.2 Global Phytohemagglutinin (PHA) Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Phytohemagglutinin (PHA), Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Phytohemagglutinin (PHA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Phytohemagglutinin (PHA) Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Phytohemagglutinin (PHA), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Phytohemagglutinin (PHA), Product Offered and Application
2.8 Global Key Manufacturers of Phytohemagglutinin (PHA), Date of Enter into This Industry
2.9 Phytohemagglutinin (PHA) Market Competitive Situation and Trends
2.9.1 Phytohemagglutinin (PHA) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Phytohemagglutinin (PHA) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Phytohemagglutinin (PHA) Production by Region
3.1 Global Phytohemagglutinin (PHA) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Phytohemagglutinin (PHA) Production Value by Region (2018-2029)
3.2.1 Global Phytohemagglutinin (PHA) Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Phytohemagglutinin (PHA) by Region (2024-2029)
3.3 Global Phytohemagglutinin (PHA) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Phytohemagglutinin (PHA) Production by Region (2018-2029)
3.4.1 Global Phytohemagglutinin (PHA) Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Phytohemagglutinin (PHA) by Region (2024-2029)
3.5 Global Phytohemagglutinin (PHA) Market Price Analysis by Region (2018-2023)
3.6 Global Phytohemagglutinin (PHA) Production and Value, Year-over-Year Growth
3.6.1 North America Phytohemagglutinin (PHA) Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Phytohemagglutinin (PHA) Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Phytohemagglutinin (PHA) Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Phytohemagglutinin (PHA) Production Value Estimates and Forecasts (2018-2029)
4 Phytohemagglutinin (PHA) Consumption by Region
4.1 Global Phytohemagglutinin (PHA) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Phytohemagglutinin (PHA) Consumption by Region (2018-2029)
4.2.1 Global Phytohemagglutinin (PHA) Consumption by Region (2018-2023)
4.2.2 Global Phytohemagglutinin (PHA) Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Phytohemagglutinin (PHA) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Phytohemagglutinin (PHA) Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Phytohemagglutinin (PHA) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Phytohemagglutinin (PHA) Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Phytohemagglutinin (PHA) Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Phytohemagglutinin (PHA) Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Phytohemagglutinin (PHA) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Phytohemagglutinin (PHA) Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Phytohemagglutinin (PHA) Production by Type (2018-2029)
5.1.1 Global Phytohemagglutinin (PHA) Production by Type (2018-2023)
5.1.2 Global Phytohemagglutinin (PHA) Production by Type (2024-2029)
5.1.3 Global Phytohemagglutinin (PHA) Production Market Share by Type (2018-2029)
5.2 Global Phytohemagglutinin (PHA) Production Value by Type (2018-2029)
5.2.1 Global Phytohemagglutinin (PHA) Production Value by Type (2018-2023)
5.2.2 Global Phytohemagglutinin (PHA) Production Value by Type (2024-2029)
5.2.3 Global Phytohemagglutinin (PHA) Production Value Market Share by Type (2018-2029)
5.3 Global Phytohemagglutinin (PHA) Price by Type (2018-2029)
6 Segment by Application
6.1 Global Phytohemagglutinin (PHA) Production by Application (2018-2029)
6.1.1 Global Phytohemagglutinin (PHA) Production by Application (2018-2023)
6.1.2 Global Phytohemagglutinin (PHA) Production by Application (2024-2029)
6.1.3 Global Phytohemagglutinin (PHA) Production Market Share by Application (2018-2029)
6.2 Global Phytohemagglutinin (PHA) Production Value by Application (2018-2029)
6.2.1 Global Phytohemagglutinin (PHA) Production Value by Application (2018-2023)
6.2.2 Global Phytohemagglutinin (PHA) Production Value by Application (2024-2029)
6.2.3 Global Phytohemagglutinin (PHA) Production Value Market Share by Application (2018-2029)
6.3 Global Phytohemagglutinin (PHA) Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Biowest
7.1.1 Biowest Phytohemagglutinin (PHA) Corporation Information
7.1.2 Biowest Phytohemagglutinin (PHA) Product Portfolio
7.1.3 Biowest Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Biowest Main Business and Markets Served
7.1.5 Biowest Recent Developments/Updates
7.2 Thermo Fisher
7.2.1 Thermo Fisher Phytohemagglutinin (PHA) Corporation Information
7.2.2 Thermo Fisher Phytohemagglutinin (PHA) Product Portfolio
7.2.3 Thermo Fisher Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Thermo Fisher Main Business and Markets Served
7.2.5 Thermo Fisher Recent Developments/Updates
7.3 Biological Industries
7.3.1 Biological Industries Phytohemagglutinin (PHA) Corporation Information
7.3.2 Biological Industries Phytohemagglutinin (PHA) Product Portfolio
7.3.3 Biological Industries Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Biological Industries Main Business and Markets Served
7.3.5 Biological Industries Recent Developments/Updates
7.4 VWR
7.4.1 VWR Phytohemagglutinin (PHA) Corporation Information
7.4.2 VWR Phytohemagglutinin (PHA) Product Portfolio
7.4.3 VWR Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.4.4 VWR Main Business and Markets Served
7.4.5 VWR Recent Developments/Updates
7.5 Francelab
7.5.1 Francelab Phytohemagglutinin (PHA) Corporation Information
7.5.2 Francelab Phytohemagglutinin (PHA) Product Portfolio
7.5.3 Francelab Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Francelab Main Business and Markets Served
7.5.5 Francelab Recent Developments/Updates
7.6 Jain Biologicals
7.6.1 Jain Biologicals Phytohemagglutinin (PHA) Corporation Information
7.6.2 Jain Biologicals Phytohemagglutinin (PHA) Product Portfolio
7.6.3 Jain Biologicals Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Jain Biologicals Main Business and Markets Served
7.6.5 Jain Biologicals Recent Developments/Updates
7.7 R&D Systems
7.7.1 R&D Systems Phytohemagglutinin (PHA) Corporation Information
7.7.2 R&D Systems Phytohemagglutinin (PHA) Product Portfolio
7.7.3 R&D Systems Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.7.4 R&D Systems Main Business and Markets Served
7.7.5 R&D Systems Recent Developments/Updates
7.8 Serox GmbH
7.8.1 Serox GmbH Phytohemagglutinin (PHA) Corporation Information
7.8.2 Serox GmbH Phytohemagglutinin (PHA) Product Portfolio
7.8.3 Serox GmbH Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Serox GmbH Main Business and Markets Served
7.7.5 Serox GmbH Recent Developments/Updates
7.9 Irvine Scientific
7.9.1 Irvine Scientific Phytohemagglutinin (PHA) Corporation Information
7.9.2 Irvine Scientific Phytohemagglutinin (PHA) Product Portfolio
7.9.3 Irvine Scientific Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Irvine Scientific Main Business and Markets Served
7.9.5 Irvine Scientific Recent Developments/Updates
7.10 Cellseco
7.10.1 Cellseco Phytohemagglutinin (PHA) Corporation Information
7.10.2 Cellseco Phytohemagglutinin (PHA) Product Portfolio
7.10.3 Cellseco Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Cellseco Main Business and Markets Served
7.10.5 Cellseco Recent Developments/Updates
7.11 Cytiva
7.11.1 Cytiva Phytohemagglutinin (PHA) Corporation Information
7.11.2 Cytiva Phytohemagglutinin (PHA) Product Portfolio
7.11.3 Cytiva Phytohemagglutinin (PHA) Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Cytiva Main Business and Markets Served
7.11.5 Cytiva Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Phytohemagglutinin (PHA) Industry Chain Analysis
8.2 Phytohemagglutinin (PHA) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Phytohemagglutinin (PHA) Production Mode & Process
8.4 Phytohemagglutinin (PHA) Sales and Marketing
8.4.1 Phytohemagglutinin (PHA) Sales Channels
8.4.2 Phytohemagglutinin (PHA) Distributors
8.5 Phytohemagglutinin (PHA) Customers
9 Phytohemagglutinin (PHA) Market Dynamics
9.1 Phytohemagglutinin (PHA) Industry Trends
9.2 Phytohemagglutinin (PHA) Market Drivers
9.3 Phytohemagglutinin (PHA) Market Challenges
9.4 Phytohemagglutinin (PHA) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer